PORTAL OLM - NOTÍCIAS, ENTRE E ESPORTES

NOTÍCIAS, JOGOS AO VIVO, ESPORTES, REALITY SHOWS E MAIS

noticias

Cras Eugênio de Melo realiza atividades sobre igualdade racial

Byadmin

mar 22, 2024

Ariane Caldas


Secretaria de Apoio Social ao Cidadão

O Cras Eugênio de Melo reuniu na tarde desta sexta-feira (22) diversas atividades em conscientização ao Dia Internacional de Combate à Discriminação Racial, celebrado em 21 de março.

A ação teve inicio com uma roda de conversa sobre letramento racial. As crianças participaram ativamente e contribuíram levantando questões do dia a dia. O objetivo foi explicar e conscientizar os pequenos sobre expressões que podem transmitir estereótipos, preconceitos ou discriminações.

Para o Yuri Cauã Moreira da Silva foi um momento para aprender um pouco mais sobre como combater o racismo. Aos 10 anos, ele já sabe como a luta é importante. “As pessoas acham que são melhores que as outras pela cor, mas não é assim, tem que respeitar”, disse.

Já Manuelle Mesquita Pereira, 10 anos, a melhor forma de acabar com o preconceito é com informação. “Tem que falar para todo mundo, postar vídeo e tudo mais”, destacou.

Durante a tarde, os participantes também aprenderam a fazer as bonecas Abayomi, confeccionadas com retalhos de tecidos, elas são símbolo de força e resistência da cultura africana.

O Cras também recebeu a exposição itinerante Beleza dos Tons, com 20 imagens de mulheres negras captadas pela fotógrafa joseense Larissa Isis.

Até o fim do mês, as atividades serão desenvolvidas em outros equipamentos da assistência social. Confira a galeria de fotos.

 

 


MAIS NOTÍCIAS

Secretaria de Apoio Social ao Cidadão

By admin

Related Post

noticias

Conict 2026 recebe trabalhos de estudantes e pesquisadores até 10 de agosto – IFSP

jul 8, 2026 admin
noticias

Serviços de manutenção da Seinfra serão realizados em 32 bairros diferentes de João Pessoa

jul 8, 2026 admin
noticias

Defensores pedem regras mais rígidas para publicidade das bets 

jul 7, 2026
121 thoughts on “Cras Eugênio de Melo realiza atividades sobre igualdade racial”

  1. Beginners Anabolic Cycle

    Beginner‑Level Testosterone Replacement Program (TRT)

    Prepared for clinicians who want a concise, evidence‑based reference that does not endorse
    specific brands.

    —

    1. Core Principles

    Principle Rationale

    Individualized dosing Patients differ in age, comorbidities, baseline
    hormone levels, and response to therapy. Start low, titrate up.

    Monitoring for efficacy & safety Regular labs (total testosterone, free/estradiol, CBC, CMP) and symptom tracking are mandatory.

    Adjunct care Address lifestyle factors (nutrition, exercise,
    sleep), treat underlying conditions (hypothyroidism, sleep apnea),
    and consider bone density or cardiovascular risk if indicated.

    —

    2. Baseline Work‑Up

    History & Physical

    – Symptoms: libido loss, fatigue, mood changes, erectile dysfunction,
    muscle weakness, gait instability.

    – Comorbidities: diabetes, hypertension, obesity, sleep apnea, psychiatric illness.

    Laboratory Panel

    | Test | Purpose |
    |——|———|
    | Total testosterone (morning 7‑10 am) | Baseline
    hormone level |
    | LH & FSH | Differentiate primary vs secondary hypogonadism |
    | Estradiol | Detect estrogen excess in men on aromatase
    inhibitors |
    | Prolactin | Rule out pituitary causes |
    | CBC, CMP | Baseline organ function |
    | PSA | Baseline prostate status (important
    for future monitoring) |

    Imaging

    – Pituitary MRI if clinical features of pituitary
    dysfunction or abnormal LH/FSH.
    – Brain CT/MRI if neurological symptoms present.

    Special Tests

    – If hypogonadism suspected, perform a hCG stimulation test to confirm Leydig cell function.

    2. Hormonal Evaluation and Interpretation

    Test Normal Range (adult male) Clinical Relevance

    LH 1–8 IU/L Low LH → primary hypogonadism; high LH → secondary failure

    FSH 1.5–12 IU/L Similar interpretation as LH

    Testosterone (total) 300–1000 ng/dL Hypo‑ or hyperandrogenic states

    Estradiol (E2) 38 °C, chills, or pain that worsens, seek emergency care (ER)
    as these could indicate infection requiring antibiotics.

    Seek urgent outpatient care: Many clinics offer
    same‑day appointments; contact a local urgent‑care clinic or walk‑in office and explain your symptoms.
    Bring your medical record if possible.

    4. How to “Know” You’re Sick vs. Feeling Unwell

    Symptom Likely Infection (needs evaluation) Likely General Malaise/Stress

    Fever >38 °C, chills, sweating Yes – seek care No

    Rapid breathing, shortness of breath Yes – urgent assessment No

    Chest pain or pressure Yes – evaluate for cardiac causes No

    Persistent cough with sputum (especially if foul‑smelling)
    Yes – could be bacterial Mild

    Severe headache + stiff neck Yes – meningitis risk No

    Confusion, dizziness, weakness Yes – monitor closely May
    improve with rest

    Generalized body aches & fatigue that improves over days
    No – likely viral recovery Yes

    —

    Bottom line

    Treat as you would a mild bacterial sinus infection: use an appropriate antibiotic (e.g., amoxicillin‑clavulanate
    500 mg/125 mg BID for 10 days).

    Give supportive care (acetaminophen or ibuprofen, saline nasal
    rinses, adequate fluids, rest).

    Watch for red flags. If symptoms worsen, you develop high fever (>38.5 °C), severe facial pain, swelling,
    vision changes, confusion, or if symptoms persist beyond 10–14 days,
    seek urgent medical care.

    This plan balances the likelihood of a bacterial infection with judicious
    antibiotic use and close monitoring for complications.

    References:

    pct cycle after dianabol

  3. After just two weeks of using Anavar, many users—especially women—begin to notice
    subtle yet encouraging changes that set the tone for the rest of their cycle.
    The early effects are often a mix of improved body composition, increased energy levels,
    and mild aesthetic enhancements that make the commitment feel worthwhile.

    Anavar Results After 2 Weeks For Females

    During the first fortnight, most female users report an immediate
    boost in stamina during workouts, allowing them to push through sets with greater confidence.

    Because Anavar is known for its gentle nature compared to other anabolic steroids, women typically
    experience a reduction in body fat that manifests as a more toned midsection and slimmer waistline.

    Muscle definition starts to become visible, particularly around the arms,
    shoulders, and calves. Even though significant muscle growth usually takes
    longer, the early weeks provide a noticeable tightening of soft tissues,
    giving users a clearer sense of progress.

    Anavar for Women

    Women often choose Anavar for its low androgenic activity, which minimizes the risk of virilization—a common concern with
    more potent steroids. The compound’s mild nature means that
    side effects such as acne or hair loss are usually mild and manageable when proper skin care is followed.

    For those looking to enhance athletic performance without
    drastic weight gain, Anavar offers a balanced approach: it supports
    lean muscle retention while promoting fat loss. Many female athletes report feeling lighter and
    more agile after just two weeks, which translates into better sprint times, improved
    endurance, and quicker recovery between sessions.

    Average Dosage

    The recommended starting dose for women is
    typically lower than for men due to differences in body composition and hormone sensitivity.

    A common regimen begins at 10 mg per day for the first week
    and may increase to 20–25 mg per day by the second week, depending on individual
    tolerance. Some users find that staying within this range provides sufficient stimulus for fat loss while keeping side effects minimal.
    It is essential to monitor how your body reacts; if any signs
    of excess virilization or liver strain appear, reducing the dose
    or stopping the cycle is advised.

    In summary, after two weeks on Anavar, female users can expect enhanced workout
    performance, visible muscle definition, and a reduction in body fat—all achieved
    with a dosage that prioritizes safety. These early results are often enough to motivate continued use while maintaining awareness of personal limits and
    health considerations.

  7. CJC 1295 and Ipamorelin are two peptides that
    have attracted attention in the fields of anti‑aging, sports performance, and medical research due to their
    potential to stimulate growth hormone release. While many
    users report benefits such as increased muscle mass, improved
    recovery, and enhanced fat loss, it is essential to be aware of possible side effects associated with these compounds.

    This guide provides a thorough overview of the known adverse reactions, mechanisms behind them, and practical
    tips for minimizing risk.

    CJC 1295 Ipamorelin Side Effects: A Comprehensive Guide

    Understanding CJC 1295 Ipamorelin

    What Are CJC 1295 and Ipamorelin?

    The following sections break down each aspect of these peptides so that you can make an informed decision about their
    use.

    Understanding the Basics

    Mechanism of Action

    Common Side Effects

    Rare or Severe Reactions

    Long‑Term Considerations

    Managing and Mitigating Risks

    1. Understanding the Basics

    CJC 1295 is a synthetic growth hormone‑releasing hormone analogue that binds to receptors in the pituitary gland,
    prompting the secretion of growth hormone (GH) and insulin‑like growth
    factor‑1 (IGF‑1). tesamorelin ipamorelin blend side effects is
    a ghrelin receptor agonist that also stimulates GH release but with a different binding profile.
    When used together, they are believed to provide synergistic stimulation of endogenous
    GH production.

    Because these peptides act on hormonal pathways, the side effect profile often mirrors other growth hormone
    therapies such as recombinant human GH or long‑acting analogues.
    The most frequently reported issues involve fluid retention, joint discomfort, and changes in metabolic parameters.

    —

    2. Mechanism of Action

    CJC 1295 increases circulating GH by mimicking natural GHRH.
    Its extended half‑life allows for sustained stimulation after a single injection per week.

    Ipamorelin mimics ghrelin, the “hunger hormone,” but is selective for GH release without significantly affecting
    appetite or cortisol levels.

    Together they produce higher peaks of GH and IGF‑1 than either agent alone.
    This amplified effect can amplify both desired outcomes (muscle growth, fat loss) and unwanted side effects.

    3. Common Side Effects

    The following adverse reactions are reported by a majority of users who take CJC 1295 or Ipamorelin in standard dosing regimens:

    3.1 Injection Site Reactions

    Redness, swelling, or mild pain at the injection site

    Rarely, bruising or small hematomas

    Occur more often when injections are given subcutaneously

    3.2 Fluid Retention (Edema)

    Swelling in extremities, especially ankles and feet

    Mild bloating or puffiness of the face

    Can be mitigated by staying hydrated and
    using compression stockings

    3.3 Joint and Muscle Pain

    Aching shoulders, knees, hips, or lower back

    Often described as “tightness” rather than sharp pain

    Usually resolves after a few days of use or when dosage is
    reduced

    3.4 Headaches and Migraine Triggers

    Mild to moderate throbbing headaches

    May be related to changes in blood pressure or
    fluid balance

    3.5 Fatigue and Sleep Disturbances

    Some users report feeling drowsy during the day or having trouble falling asleep at night

    Adjusting injection timing (e.g., early morning vs late evening)
    can help

    3.6 Increased Appetite or Weight Gain

    Though Ipamorelin is less appetite‑stimulating than other ghrelin analogues,
    some users notice a slight increase in hunger

    The effect is usually modest and can be countered with
    balanced nutrition

    3.7 Skin Changes

    Occasional acne flare-ups or increased oiliness

    Mild redness or flushing after injection

    4. Rare or Severe Reactions

    Although uncommon, certain serious side effects have been documented in clinical studies and
    anecdotal reports:

    4.1 Hypoglycemia

    Growth hormone can counteract insulin action, potentially raising blood glucose levels

    In rare cases, the opposite effect—lowered glucose—has been observed, especially when combined with other hormonal agents

    4.2 Hypertension or Cardiovascular Stress

    Elevated blood pressure readings have been noted in a small subset of users

    Monitoring systolic and diastolic pressures before starting
    therapy is advisable

    4.3 Carpal Tunnel Syndrome

    Repeated GH stimulation may increase fluid around the wrist, leading to nerve compression symptoms

    4.4 Thyroid Dysfunction

    Some patients experience changes in thyroid hormone levels; routine screening can catch early abnormalities

    4.5 Hormonal Imbalance in Women

    In women, excessive GH release may alter menstrual cycles or lead to ovarian cysts

    Hormone‑monitoring protocols are recommended for female users

    5. Long‑Term Considerations

    The long‑term safety profile of CJC 1295 and Ipamorelin remains under investigation. Potential concerns include:

    Cancer Risk: Elevated IGF‑1 levels have been linked to
    increased proliferation in certain cell types, though definitive evidence for these peptides is limited.

    Endocrine Resistance: Prolonged overstimulation may blunt the
    body’s natural GH production pathways.

    Metabolic Alterations: Chronic use could affect insulin sensitivity and lipid profiles.

    For users considering extended therapy (more than 12–18 weeks),
    periodic medical evaluation—including blood tests for liver enzymes,
    thyroid function, fasting glucose, and lipid panels—is strongly recommended.

    6. Managing and Mitigating Risks

    Below are practical strategies to reduce the likelihood of adverse reactions:

    Start Low, Go Slow

    – Begin with a minimal dose (e.g., 100–150 µg per injection) and gradually increase only if tolerated.

    Monitor Injection Technique

    – Use clean needles, rotate sites regularly, and keep injections at a consistent angle to avoid bruising.

    Hydration and Electrolytes

    – Drink plenty of water and consider electrolytes (magnesium, potassium) to counter fluid
    retention.

    Timing of Injections

    – Administer in the morning to align with natural circadian GH
    peaks and reduce nighttime sleep disturbances.

    Dietary Adjustments

    – Limit high‑sugar foods that may interfere with insulin sensitivity; focus on balanced protein, healthy fats,
    and complex carbohydrates.

    Regular Health Checks

    – Schedule blood work every 3–6 months to track GH, IGF‑1, glucose, thyroid, and lipid levels.

    Use of Adjunctive Therapies

    – Some users incorporate antioxidants or anti‑inflammatory
    supplements (e.g., turmeric, omega‑3s) to ease
    joint discomfort.

    Awareness of Symptoms

    – Recognize early signs of severe reactions such as sudden swelling, chest pain, fainting, or persistent headaches and seek
    medical help promptly.

    Conclusion

    CJC 1295 and Ipamorelin offer a potent means of stimulating
    natural growth hormone production, with benefits
    that appeal to both athletes and individuals seeking anti‑aging effects.
    However, the hormonal manipulation involved carries a spectrum of side effects—from mild injection site irritation to
    more serious cardiovascular or endocrine disturbances.
    By understanding these risks, starting conservatively,
    monitoring health parameters closely, and adopting supportive lifestyle measures, users can maximize benefits while minimizing potential
    harm.

    —

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *

You missed

noticias

Conict 2026 recebe trabalhos de estudantes e pesquisadores até 10 de agosto – IFSP

jul 8, 2026 admin
noticias

Serviços de manutenção da Seinfra serão realizados em 32 bairros diferentes de João Pessoa

jul 8, 2026 admin
noticias

Defensores pedem regras mais rígidas para publicidade das bets 

jul 7, 2026
noticias

AUTORIZAÇÃO DE INEXIGIBILIDADE DE LICITAÇÃO Nº 19/2026 – Prefeitura Municipal de Bonito

jul 7, 2026 admin